First Trust Advisors’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
First Trust Advisors's DNTH Position: Q3 2026 in Review
First Trust Advisors increased its Dianthus Therapeutics (DNTH) stake by 42% in Q3 2026, buying an estimated $4.12M and bringing the position to 133,810 shares worth $11.8M. The position accounts for 0.01% of the portfolio, ranked #1127.
First Trust Advisors first reported a position in DNTH in Q3 2021 and has held it in 6 quarters since. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- First Trust Advisors held 133,810 shares of Dianthus Therapeutics worth $11.8M as of Q3 2026.
- First Trust Advisors bought 39,658 Dianthus Therapeutics shares in Q3 2026, an estimated $4.12M.
- Dianthus Therapeutics made up 0.01% of First Trust Advisors's portfolio in Q3 2026, its #1127 holding.
- First Trust Advisors first reported a position in Dianthus Therapeutics in Q3 2021 and has held it in 6 quarters since.
- 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.